| Autor: |
Otake H; Faculty of Pharmacy, Kindai University., Mano Y; Department of Pharmacy, Belland General Hospital., Deguchi S; Faculty of Pharmacy, Kindai University., Ogata F; Faculty of Pharmacy, Kindai University., Kawasaki N; Faculty of Pharmacy, Kindai University., Nagai N; Faculty of Pharmacy, Kindai University. |
| Jazyk: |
angličtina |
| Zdroj: |
Biological & pharmaceutical bulletin [Biol Pharm Bull] 2023; Vol. 46 (5), pp. 707-712. |
| DOI: |
10.1248/bpb.b22-00871 |
| Abstrakt: |
Wound-healing deficits of the skin, one of the most common complications in patients with diabetes, delay wound healing, significantly reducing the patient's QOL. Therefore, the topical treatment of wound areas with drug-containing ointments and dressings is important. In this study, we investigated the effect of various ointment bases on skin wound healing in normal and streptozotocin-induced diabetic rats (STZ rats). Three ointment bases were used: white ointment (oil-based), absorbent cream (emulsion-based, w/o), and macrogol ointment (water-based). Skin wound healing in STZ rats was delayed compared with that in normal rats. Each of the three ointment bases was applied to the skin wound area in normal rats, and there was no difference in the therapeutic effect. The therapeutic effect of both white ointment and absorbent cream was higher in the STZ rats group than that in the non-treated group, and delayed wound healing was observed in STZ rats treated with macrogol ointment. In conclusion, skin wound healing in STZ rats is affected by the properties of the ointment base, and it is important to use an ointment base that controls the drying of the wound area in STZ rats. These findings provide information for the selection of ointment bases useful for application to skin wounds in patients with diabetes. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
